ref_name,subject_name,vaccination_date_cmp,vaccination_date,vaccine_name,dosage,location,section
Vikse23,mRNA_3dose,~,2021-12-01,mRNA-monovalent,3,Norway,NULL
Vikse23,mRNA_2or3dose_BA.1/2_BTI,~,2021-12-01,mRNA-monovalent,3,Norway,NULL
Vikse23,mRNA_2or3dose_BA.5_BTI,~,2021-12-01,mRNA-monovalent,3,Norway,NULL
Vikse23,P1,~,2021-12-01,mRNA-monovalent,3,Norway,NULL
Vikse23,P2,~,2021-12-01,mRNA-monovalent,2,Norway,NULL
Vikse23,P3,~,2021-12-01,mRNA-monovalent,3,Norway,NULL
Vikse23,P4,~,2021-12-01,mRNA-monovalent,3,Norway,NULL
Vikse23,P5,~,2021-12-01,mRNA-monovalent,3,Norway,NULL
Vikse23,P6,~,2021-12-01,mRNA-monovalent,3,Norway,NULL
Vikse23,P7,~,2021-12-01,mRNA-monovalent,2,Norway,NULL
Vikse23,P8,~,2021-12-01,mRNA-monovalent,3,Norway,NULL
Vikse23,P9,~,2021-12-01,mRNA-monovalent,3,Norway,NULL
Vikse23,P10,~,2021-12-01,mRNA-monovalent,3,Norway,NULL
Vikse23,P11,~,2021-12-01,mRNA-monovalent,3,Norway,NULL
Vikse23,P12,~,2021-12-01,mRNA-monovalent,3,Norway,NULL
Vikse23,P13,~,2021-12-01,mRNA-monovalent,3,Norway,NULL
Vikse23,P14,~,2021-12-01,mRNA-monovalent,3,Norway,NULL
Vikse23,P15,~,2021-12-01,mRNA-monovalent,3,Norway,NULL
Vikse23,P16,~,2021-12-01,mRNA-monovalent,3,Norway,NULL
Vikse23,P17,~,2021-12-01,mRNA-monovalent,2,Norway,NULL
Vikse23,P18,~,2021-12-01,mRNA-monovalent,3,Norway,NULL
Vikse23,P19,~,2021-12-01,mRNA-monovalent,3,Norway,NULL
Vikse23,P20,~,2021-12-01,mRNA-monovalent,3,Norway,NULL
Vikse23,P21,~,2021-12-01,mRNA-monovalent,2,Norway,NULL
Vikse23,P22,~,2021-12-01,mRNA-monovalent,3,Norway,NULL
Vikse23,P23,~,2021-12-01,mRNA-monovalent,3,Norway,NULL
Vikse23,P24,~,2021-12-01,mRNA-monovalent,3,Norway,NULL
Vikse23,P25,~,2021-12-01,mRNA-monovalent,2,Norway,NULL
Vikse23,P26,~,2021-12-01,mRNA-monovalent,3,Norway,NULL
Vikse23,P27,~,2021-12-01,mRNA-monovalent,3,Norway,NULL
Vikse23,P28,~,2021-12-01,mRNA-monovalent,3,Norway,NULL
Vikse23,P29,~,2021-12-01,mRNA-monovalent,3,Norway,NULL
Vikse23,P30,~,2021-12-01,mRNA-monovalent,3,Norway,NULL
Vikse23,P31,~,2021-12-01,mRNA-monovalent,3,Norway,NULL
Vikse23,P32,~,2021-12-01,mRNA-monovalent,3,Norway,NULL
Vikse23,P32,~,2021-08-01,mRNA-bivalent,4,Norway,NULL
